BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15977423)

  • 1. Selectivity assessment of kinase inhibitors: strategies and challenges.
    Luo Y
    Curr Opin Mol Ther; 2005 Jun; 7(3):251-5. PubMed ID: 15977423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinomics: characterizing the therapeutically validated kinase space.
    Vieth M; Sutherland JJ; Robertson DH; Campbell RM
    Drug Discov Today; 2005 Jun; 10(12):839-46. PubMed ID: 15970266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
    Laufer SA; Domeyer DM; Scior TR; Albrecht W; Hauser DR
    J Med Chem; 2005 Feb; 48(3):710-22. PubMed ID: 15689155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the design of selective ATP-competitive kinase inhibitors].
    Deng XQ; Xiang ML; Jia R; Yang SY
    Yao Xue Xue Bao; 2007 Dec; 42(12):1232-6. PubMed ID: 18338633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
    Prudent R; Cochet C
    Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A priori inference of cross reactivity for drug-targeted kinases.
    Fernandez A; Maddipati S
    J Med Chem; 2006 Jun; 49(11):3092-100. PubMed ID: 16722629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
    Sheinerman FB; Giraud E; Laoui A
    J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemogenomics: structuring the drug discovery process to gene families.
    Harris CJ; Stevens AP
    Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural approaches to obtain kinase selectivity.
    Norman RA; Toader D; Ferguson AD
    Trends Pharmacol Sci; 2012 May; 33(5):273-8. PubMed ID: 22503441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small kinase assay panels can provide a measure of selectivity.
    Brandt P; Jensen AJ; Nilsson J
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5861-3. PubMed ID: 19748779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors.
    Liao JJ
    J Med Chem; 2007 Feb; 50(3):409-24. PubMed ID: 17266192
    [No Abstract]   [Full Text] [Related]  

  • 12. The identification of new protein kinase inhibitors as targets in modern drug discovery.
    Akritopoulou-Zanze I
    IDrugs; 2006 Jul; 9(7):481-7. PubMed ID: 16821161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a pharmacophore for kinase frequent hitters.
    Aronov AM; Murcko MA
    J Med Chem; 2004 Nov; 47(23):5616-9. PubMed ID: 15509160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.
    Cox KJ; Shomin CD; Ghosh I
    Future Med Chem; 2011 Jan; 3(1):29-43. PubMed ID: 21428824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput kinase profiling as a platform for drug discovery.
    Goldstein DM; Gray NS; Zarrinkar PP
    Nat Rev Drug Discov; 2008 May; 7(5):391-7. PubMed ID: 18404149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    Aronov AM; McClain B; Moody CS; Murcko MA
    J Med Chem; 2008 Mar; 51(5):1214-22. PubMed ID: 18288794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence and structural analysis of kinase ATP pocket residues.
    Vulpetti A; Bosotti R
    Farmaco; 2004 Oct; 59(10):759-65. PubMed ID: 15474052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design strategies for protein kinase inhibitors.
    Parang K; Sun G
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):617-29. PubMed ID: 15503864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.